Nagoya, Medicine
Material Transfer Agreement (MTA) for the development of novel anti-CD19 and CD37 chimeric antigen receptor T-cells. This collaboration aims to expand the research and development of the treatment for clinical use and to strengthen the collaboration between the universities through a Memorandum of Understanding (MOU).
Seitaro Terakura
Qualification
- MD, PhD
Title and Affiliation
Clinical Lecturer, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
Email: [email protected]
Link: https://profs.provost.nagoya-u.ac.jp/html/100007792_en.html